The global Anti-aging Drugs market size was valued at USD 9078.5 million in 2022 and is forecast to a readjusted size of USD 19310 million by 2029 with a CAGR of 11.4% during review period.
Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
The industry's leading producers are Allergan, Galderma and LG Life Science, with revenue ratios of 41.40%, 16.45% and 8.36%, respectively, in 2019.
This report is a detailed and comprehensive analysis for global Anti-aging Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-aging Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Anti-aging Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Anti-aging Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Anti-aging Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-aging Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-aging Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech
Dermal Fillers
Botulinum Toxin
Others
Hospital
Beauty Parlor
Others
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Anti-aging Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-aging Drugs, with price, sales, revenue and global market share of Anti-aging Drugs from 2018 to 2023.
Chapter 3, the Anti-aging Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-aging Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anti-aging Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-aging Drugs.
Chapter 14 and 15, to describe Anti-aging Drugs sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Anti-aging Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-aging Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Dermal Fillers
1.3.3 Botulinum Toxin
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-aging Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Beauty Parlor
1.4.4 Others
1.5 Global Anti-aging Drugs Market Size & Forecast
1.5.1 Global Anti-aging Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-aging Drugs Sales Quantity (2018-2029)
1.5.3 Global Anti-aging Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Anti-aging Drugs Product and Services
2.1.4 Allergan Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Allergan Recent Developments/Updates
2.2 Galderma
2.2.1 Galderma Details
2.2.2 Galderma Major Business
2.2.3 Galderma Anti-aging Drugs Product and Services
2.2.4 Galderma Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Galderma Recent Developments/Updates
2.3 LG Life Science
2.3.1 LG Life Science Details
2.3.2 LG Life Science Major Business
2.3.3 LG Life Science Anti-aging Drugs Product and Services
2.3.4 LG Life Science Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 LG Life Science Recent Developments/Updates
2.4 Merz Pharma
2.4.1 Merz Pharma Details
2.4.2 Merz Pharma Major Business
2.4.3 Merz Pharma Anti-aging Drugs Product and Services
2.4.4 Merz Pharma Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merz Pharma Recent Developments/Updates
2.5 Medytox
2.5.1 Medytox Details
2.5.2 Medytox Major Business
2.5.3 Medytox Anti-aging Drugs Product and Services
2.5.4 Medytox Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Medytox Recent Developments/Updates
2.6 Hugel
2.6.1 Hugel Details
2.6.2 Hugel Major Business
2.6.3 Hugel Anti-aging Drugs Product and Services
2.6.4 Hugel Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hugel Recent Developments/Updates
2.7 IMEIK
2.7.1 IMEIK Details
2.7.2 IMEIK Major Business
2.7.3 IMEIK Anti-aging Drugs Product and Services
2.7.4 IMEIK Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 IMEIK Recent Developments/Updates
2.8 Haohai Bio
2.8.1 Haohai Bio Details
2.8.2 Haohai Bio Major Business
2.8.3 Haohai Bio Anti-aging Drugs Product and Services
2.8.4 Haohai Bio Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Haohai Bio Recent Developments/Updates
2.9 Daewoong Pharmaceutical
2.9.1 Daewoong Pharmaceutical Details
2.9.2 Daewoong Pharmaceutical Major Business
2.9.3 Daewoong Pharmaceutical Anti-aging Drugs Product and Services
2.9.4 Daewoong Pharmaceutical Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Daewoong Pharmaceutical Recent Developments/Updates
2.10 Bloomage
2.10.1 Bloomage Details
2.10.2 Bloomage Major Business
2.10.3 Bloomage Anti-aging Drugs Product and Services
2.10.4 Bloomage Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bloomage Recent Developments/Updates
2.11 Suneva Medical
2.11.1 Suneva Medical Details
2.11.2 Suneva Medical Major Business
2.11.3 Suneva Medical Anti-aging Drugs Product and Services
2.11.4 Suneva Medical Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Suneva Medical Recent Developments/Updates
2.12 SciVision Biotech
2.12.1 SciVision Biotech Details
2.12.2 SciVision Biotech Major Business
2.12.3 SciVision Biotech Anti-aging Drugs Product and Services
2.12.4 SciVision Biotech Anti-aging Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 SciVision Biotech Recent Developments/Updates
3 Competitive Environment: Anti-aging Drugs by Manufacturer
3.1 Global Anti-aging Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-aging Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Anti-aging Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-aging Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-aging Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-aging Drugs Manufacturer Market Share in 2022
3.5 Anti-aging Drugs Market: Overall Company Footprint Analysis
3.5.1 Anti-aging Drugs Market: Region Footprint
3.5.2 Anti-aging Drugs Market: Company Product Type Footprint
3.5.3 Anti-aging Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-aging Drugs Market Size by Region
4.1.1 Global Anti-aging Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-aging Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Anti-aging Drugs Average Price by Region (2018-2029)
4.2 North America Anti-aging Drugs Consumption Value (2018-2029)
4.3 Europe Anti-aging Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-aging Drugs Consumption Value (2018-2029)
4.5 South America Anti-aging Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-aging Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-aging Drugs Sales Quantity by Type (2018-2029)
5.2 Global Anti-aging Drugs Consumption Value by Type (2018-2029)
5.3 Global Anti-aging Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-aging Drugs Sales Quantity by Application (2018-2029)
6.2 Global Anti-aging Drugs Consumption Value by Application (2018-2029)
6.3 Global Anti-aging Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-aging Drugs Sales Quantity by Type (2018-2029)
7.2 North America Anti-aging Drugs Sales Quantity by Application (2018-2029)
7.3 North America Anti-aging Drugs Market Size by Country
7.3.1 North America Anti-aging Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-aging Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-aging Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Anti-aging Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Anti-aging Drugs Market Size by Country
8.3.1 Europe Anti-aging Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-aging Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-aging Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-aging Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-aging Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-aging Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-aging Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-aging Drugs Sales Quantity by Type (2018-2029)
10.2 South America Anti-aging Drugs Sales Quantity by Application (2018-2029)
10.3 South America Anti-aging Drugs Market Size by Country
10.3.1 South America Anti-aging Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-aging Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-aging Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-aging Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-aging Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-aging Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-aging Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-aging Drugs Market Drivers
12.2 Anti-aging Drugs Market Restraints
12.3 Anti-aging Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-aging Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-aging Drugs
13.3 Anti-aging Drugs Production Process
13.4 Anti-aging Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-aging Drugs Typical Distributors
14.3 Anti-aging Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Anti-aging Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-aging Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan Anti-aging Drugs Product and Services
Table 6. Allergan Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Allergan Recent Developments/Updates
Table 8. Galderma Basic Information, Manufacturing Base and Competitors
Table 9. Galderma Major Business
Table 10. Galderma Anti-aging Drugs Product and Services
Table 11. Galderma Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Galderma Recent Developments/Updates
Table 13. LG Life Science Basic Information, Manufacturing Base and Competitors
Table 14. LG Life Science Major Business
Table 15. LG Life Science Anti-aging Drugs Product and Services
Table 16. LG Life Science Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. LG Life Science Recent Developments/Updates
Table 18. Merz Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Merz Pharma Major Business
Table 20. Merz Pharma Anti-aging Drugs Product and Services
Table 21. Merz Pharma Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merz Pharma Recent Developments/Updates
Table 23. Medytox Basic Information, Manufacturing Base and Competitors
Table 24. Medytox Major Business
Table 25. Medytox Anti-aging Drugs Product and Services
Table 26. Medytox Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Medytox Recent Developments/Updates
Table 28. Hugel Basic Information, Manufacturing Base and Competitors
Table 29. Hugel Major Business
Table 30. Hugel Anti-aging Drugs Product and Services
Table 31. Hugel Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hugel Recent Developments/Updates
Table 33. IMEIK Basic Information, Manufacturing Base and Competitors
Table 34. IMEIK Major Business
Table 35. IMEIK Anti-aging Drugs Product and Services
Table 36. IMEIK Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. IMEIK Recent Developments/Updates
Table 38. Haohai Bio Basic Information, Manufacturing Base and Competitors
Table 39. Haohai Bio Major Business
Table 40. Haohai Bio Anti-aging Drugs Product and Services
Table 41. Haohai Bio Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Haohai Bio Recent Developments/Updates
Table 43. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Daewoong Pharmaceutical Major Business
Table 45. Daewoong Pharmaceutical Anti-aging Drugs Product and Services
Table 46. Daewoong Pharmaceutical Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Daewoong Pharmaceutical Recent Developments/Updates
Table 48. Bloomage Basic Information, Manufacturing Base and Competitors
Table 49. Bloomage Major Business
Table 50. Bloomage Anti-aging Drugs Product and Services
Table 51. Bloomage Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Bloomage Recent Developments/Updates
Table 53. Suneva Medical Basic Information, Manufacturing Base and Competitors
Table 54. Suneva Medical Major Business
Table 55. Suneva Medical Anti-aging Drugs Product and Services
Table 56. Suneva Medical Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Suneva Medical Recent Developments/Updates
Table 58. SciVision Biotech Basic Information, Manufacturing Base and Competitors
Table 59. SciVision Biotech Major Business
Table 60. SciVision Biotech Anti-aging Drugs Product and Services
Table 61. SciVision Biotech Anti-aging Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. SciVision Biotech Recent Developments/Updates
Table 63. Global Anti-aging Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Anti-aging Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Anti-aging Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Anti-aging Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Anti-aging Drugs Production Site of Key Manufacturer
Table 68. Anti-aging Drugs Market: Company Product Type Footprint
Table 69. Anti-aging Drugs Market: Company Product Application Footprint
Table 70. Anti-aging Drugs New Market Entrants and Barriers to Market Entry
Table 71. Anti-aging Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Anti-aging Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Anti-aging Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Anti-aging Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Anti-aging Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Anti-aging Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Anti-aging Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Anti-aging Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Anti-aging Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Anti-aging Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Anti-aging Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Anti-aging Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Anti-aging Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Anti-aging Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Anti-aging Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Anti-aging Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Anti-aging Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Anti-aging Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Anti-aging Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Anti-aging Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Anti-aging Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Anti-aging Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Anti-aging Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Anti-aging Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Anti-aging Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Anti-aging Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Anti-aging Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Anti-aging Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Anti-aging Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Anti-aging Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Anti-aging Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Anti-aging Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Anti-aging Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Anti-aging Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Anti-aging Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Anti-aging Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Anti-aging Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Anti-aging Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Anti-aging Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Anti-aging Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Anti-aging Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Anti-aging Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Anti-aging Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Anti-aging Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Anti-aging Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Anti-aging Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Anti-aging Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Anti-aging Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Anti-aging Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Anti-aging Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Anti-aging Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Anti-aging Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Anti-aging Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Anti-aging Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Anti-aging Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Anti-aging Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Anti-aging Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Anti-aging Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Anti-aging Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Anti-aging Drugs Raw Material
Table 131. Key Manufacturers of Anti-aging Drugs Raw Materials
Table 132. Anti-aging Drugs Typical Distributors
Table 133. Anti-aging Drugs Typical Customers
List of Figures
Figure 1. Anti-aging Drugs Picture
Figure 2. Global Anti-aging Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-aging Drugs Consumption Value Market Share by Type in 2022
Figure 4. Dermal Fillers Examples
Figure 5. Botulinum Toxin Examples
Figure 6. Others Examples
Figure 7. Global Anti-aging Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Anti-aging Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Beauty Parlor Examples
Figure 11. Others Examples
Figure 12. Global Anti-aging Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Anti-aging Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Anti-aging Drugs Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Anti-aging Drugs Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Anti-aging Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Anti-aging Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Anti-aging Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Anti-aging Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Anti-aging Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Anti-aging Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Anti-aging Drugs Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Anti-aging Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Anti-aging Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Anti-aging Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Anti-aging Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Anti-aging Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Anti-aging Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Anti-aging Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Anti-aging Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Anti-aging Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Anti-aging Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Anti-aging Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Anti-aging Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Anti-aging Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Anti-aging Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Anti-aging Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Anti-aging Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Anti-aging Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Anti-aging Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Anti-aging Drugs Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Anti-aging Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Anti-aging Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Anti-aging Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Anti-aging Drugs Consumption Value Market Share by Region (2018-2029)
Figure 54. China Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Anti-aging Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Anti-aging Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Anti-aging Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Anti-aging Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Anti-aging Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Anti-aging Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Anti-aging Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Anti-aging Drugs Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Anti-aging Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Anti-aging Drugs Market Drivers
Figure 75. Anti-aging Drugs Market Restraints
Figure 76. Anti-aging Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Anti-aging Drugs in 2022
Figure 79. Manufacturing Process Analysis of Anti-aging Drugs
Figure 80. Anti-aging Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
